drugset / Trial / NCT03764267

MAC vs TIVA Ambulatory Breast Augmentation

NCT03764267

Phase 3 Completed 80 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindOther

Summary

hypothesis: the combination of LA with remifentanil and ketofol \[monitored anesthesia care (MAC)\] for ambulatory breast augmentation may result in results in better QoR on day of surgery as compared with total i.v. anesthesia (TIVA) . The purpose of this study was to compare the QoR after MAC using remifentanil and ketofol with TIVA during ambulatory breast augmentation .

Timeline

Start
2014-01-01
Primary completion
2017-01-01
Completion
2018-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 10 ug/kg
Comparator Propofol Small molecule 25 ug/kg
Comparator Propofol Small molecule 5 mg/kg
Comparator Remifentanil Small molecule 0.1 ug/kg Intravenous
Comparator Remifentanil Small molecule 0.5 ug/kg Intravenous

Indications